Ferris, R. L., Cohen, E., Gash, K., Whiting, S., Manjarrez, K., Dietsch, G., . . . Bryan, J. K. (2014). Active8: A randomized, double-blind, placebo-controlled study of chemotherapy plus cetuximab in combination with TLR8 agonist VTX-2337 in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). J Immunother Cancer.
Chicago Stili AlıntıFerris, Robert L., Ezra Cohen, Kelly Gash, Sam Whiting, Kristi Manjarrez, Greg Dietsch, Robert Hershberg, ve James Kyle Bryan. "Active8: A Randomized, Double-blind, Placebo-controlled Study of Chemotherapy Plus Cetuximab in Combination With TLR8 Agonist VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)." J Immunother Cancer 2014.
MLA AlıntıFerris, Robert L., et al. "Active8: A Randomized, Double-blind, Placebo-controlled Study of Chemotherapy Plus Cetuximab in Combination With TLR8 Agonist VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)." J Immunother Cancer 2014.